The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Compounds · Secretagogues & GH axis

Evidence quality in the secretagogue literature: an honest assessment

Solved
Solved by sa.vogel in post #2
the opening post is right about the mechanism and I think understates the practical bit. GHRH analogues versus ghrelin mimetics are often conflated but they are different mechanisms. GHRH analogues (like CJC-1295) cause the pituitary to release growth hormone. Ghrelin mimetics (like GHRPs) act on the ghrelin receptor…

Jump to the accepted answer →

SS
s.salgadoTL2 Moderator2 Jul 2026#1

Evidence quality in the secretagogue literature: an honest assessment Writing it up because I had to work it out twice and would rather nobody else did.

Comparing SURMOUNT-OSA (N Engl J Med, 2024) with STEP 8 (JAMA, 2022) and finding the comparison harder than it looks.

Different populations, different durations, different endpoints defined slightly differently, and in one case a different estimand. People compare the headline percentages anyway, including me until recently.

Is there a defensible way to put these side by side, or is the honest answer that there is not and we should stop?

20 likes 26d
SV
sa.vogelTL2 Moderator Solution12 Jul 2026 · edited#2

the opening post is right about the mechanism and I think understates the practical bit.

GHRH analogues versus ghrelin mimetics are often conflated but they are different mechanisms. GHRH analogues (like CJC-1295) cause the pituitary to release growth hormone. Ghrelin mimetics (like GHRPs) act on the ghrelin receptor directly. The effect on growth hormone secretion is similar but the mechanisms are distinct.

10 likes 16d
K
KTurkingtonTL3Regular19 Jul 2026#3

IGF-1 as a surrogate: it is a better integrated measure than a spot growth hormone level and it is still a surrogate, with all the caveats that come with surrogates. Stable or rising IGF-1 is not the same as "this is working" in any health-related sense.

0 likes 9d

Suggested topics

TopicParticipantsRepliesViewsActivity
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset
The question in the title: Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset I will give what I have already checked below so nobody repeats it. I have seen LEADER ( N…
BRPDBJRMSG+60 64 25k 15mo
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence
Posting this under the heading it deserves: Tesamorelin has an approved indication — what that changes about the evidence Everything below is what sits behind that. Comparing STEP 8 ( JAMA , 2022) with…
RLHFTDIBBW+63 68 18k 14mo
Reading a rodent study on a secretagogue without over-extrapolating — the long version
Reading a rodent study on a secretagogue without over-extrapolating — the long version — setting out what I have, and where I think it stops being reliable. I have seen STEP 4 ( JAMA , 2021) cited in support…
CDDBANKBMA+59 66 30k 4h
What a well-designed human trial of a secretagogue would look like
What a well-designed human trial of a secretagogue would look like I have a specific reason for asking rather than idle curiosity, and the context is below. I have seen SUSTAIN 6 ( N Engl J Med , 2016) cited…
HORNR 2 7.2k 18mo
About the Secretagogues & GH axis category
Growth-hormone secretagogues and related compounds. Evidence quality here is markedly lower and we say so. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is…
KBNNHVSCN+6 10 1.1k 14mo

Related topics — sharing the tags ipamorelin, observational data, GHRP class

TopicParticipantsRepliesViewsActivity
Follow-up: Reading an interaction checker output critically
Reading an interaction checker output critically — setting out what I have, and where I think it stops being reliable. I have read the maintained page on this and I still have a gap, so I am asking rather…
MNWVSGSR+62 66 13k 2d
Reverse causation in a cohort study of weight and outcome — a second dataset
Reverse causation in a cohort study of weight and outcome — a second dataset Writing it up because I had to work it out twice and would rather nobody else did. Session topic: SURMOUNT-OSA ( N Engl J Med ,…
MRAKANKBVK+112 131 1.5k 10mo
Levothyroxine timing: a real interaction with a simple fix
Levothyroxine timing: a real interaction with a simple fix Writing it up because I had to work it out twice and would rather nobody else did. Reporting something rather than asking about it, in case the…
ABITMSBVNL+20 24 60k 18mo
Grapefruit: why this class is not the class that cares
Grapefruit: why this class is not the class that cares Writing it up because I had to work it out twice and would rather nobody else did. Practical question with the units stated, because I have seen how…
PEOCLTEOND+126 139 4k 4mo
TB-500 and thymosin beta-4: the fragment versus the protein
TB-500 and thymosin beta-4: the fragment versus the protein Writing it up because I had to work it out twice and would rather nobody else did. I have seen SURPASS-4 ( Lancet , 2021) cited in support of a…
COGDJLDVS+107 118 22k 11mo